
England and Wales Approve Groundbreaking HIV Prevention Injection as UK Expands Efforts to End New Cases by 2030
A Milestone for HIV Prevention in the United Kingdom For the first time, the National Health Service (NHS) in England and Wales will offer an injectable HIV prevention therapy known as cabotegravir (CAB-LA). This long-acting shot, administered every two months, offers an alternative to daily oral PrEP (pre-exposure prophylaxis) medication.











